Ligand-dependent contribution of RXRβ
RNA analyses. Total RNA was prepared using Trizol reagent (Gibco BRL). Total RNA from Rxrb af20 E12.5 embryo was reverse transcribed for 15 min at 50°C and amplified using primers 5'-CTTCGGGAGAAGGTGTACGC-3' (nt 1207-1229) and 5'-GGCAACACTTAGCAGGGTTC-3' (nt 1535-1554) to generate a 314 bp-long product (numbering according to Leid et al., 1992) . Conditions were 30 cycles with denaturation at 94°C for 30 sec, annealing at 60° C for 30 sec and elongation at 72°C for 1 min. The amplified fragment was purified on agarose gel and sequenced using primer 5'-GACGAGGAGGGGACTTGCCC-3' (nt 1496-1515), confirming deletion of region coding for RXRβ AF-2 core. Quantitative analysis of RNA was carried out by Real Time PCR (RT-PCR) using a Light-Cycler and the DNA double strand-specific SYBR Green I dye for detection (Roche). Reverse transcription of total RNA was performed at 42°C using Superscript II reverse transcriptase (Invitrogen Life Technologies) and random hexanucleotide primers. Following inactivation at 70°C for 15 min, cDNAs were purified using Qiagen kit and tested in duplicates by RT-PCR.
Results were normalized to GAPDH levels. The nucleotide sequences of the primers are available at the web site http://www-igbmc.u-strasbg.fr/Departments/Dep_V/Dep_VA/ Publi/Paper.html.
Electrophoretic mobility shift assays (EMSA).
Receptors were produced using the TNT® T7 coupled transcription-translation system (Promega) and the following expression vectors as templates : pCMX-LXRβ (gift of Dr. Mangelsdorf, Touchstone
Center for Diabetes Research, Dallas, TX), pSG5-RXRβ, pSG5-RXRβ∆AF-2 (dnRXRβ∆430-448, Nagpal et al., 1993) and pSG5-TRα (Vivat-Hannah et al., 2003) .
Protein integrity was checked by translating the template plasmids in the presence of 35 S-methionine and SDS-PAGE analysis (data not shown). The protein amounts used in each EMSA were calibrated as described previously (Zechel et al., 1994) . The corepressor used was a GST-fusion containing the C-terminal part of SMRT (residues 982 to 1495; Germain et al., 2002) . It was produced in E. coli and purified as described (Iyer et al., 1999) . When required, 1 µM 22(R)-hydroxycholesterol (Sigma) dissolved in ethanol was evaporated into the tubes. Receptors and 10 fmol of LG100268, a gift from Dr Heyman, Xceptor Therapeutics, San Diego, CA) and LXRβ (10 µM 22(R)-HC) that were dissolved in DMSO and ethanol, respectively. Cells were grown for 24h before harvesting for luciferase assay. Luciferase measurements were done according to standard protocols and normalized to β-galactosidase activity (Brendel et al., 2002) .
